Issei Saeki

15PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisSurface water quality processes and contaminated sediment assessmentApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|May 01, 2026
A Novel Diagnostic Approach for Hepatocellular Carcinoma Using Glycosylated Ferritin.

|Feb 06, 2026
Response to 'Reassessing the Clinical Interpretation of Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma'.

Ryu Sasaki, Shigeo Shimose, Issei Saeki

|Nov 28, 2025
Efficacy and Safety of Atezolizumab Plus Bevacizumab for Patients With Hepatocellular Carcinoma and Child-Pugh Class B.

Ryu Sasaki, Shigeo Shimose, Issei Saeki

|Nov 18, 2025
Validation of Liquid Biopsy Using a Methylated SEPT9 Assay and Integrated Index for Detecting Hepatocellular Carcinoma.

Issei Saeki, Yutaka Suehiro, Yurika Yamauchi

|Oct 07, 2025
Caution Regarding Short-Term Increases in Ammonia Levels Following Splenic Artery Embolization.

Tsuyoshi Ishikawa, Aika Kirihara, Natsuko Nishiyama

|Aug 21, 2025
Association of Metabolic-Associated Steatotic Liver Disease With Clinical Outcomes of Durvalumab and Tremelimumab in Advanced Hepatocellular Carcinoma Patients: A Multicenter Study.

Takeshi Hatanaka, Shigeo Shimose, Takanori Ito

Pageof 3

Frequent Collaborators

13 joint publications

Taro Takami

6 joint publications

Norikazu Tanabe

5 joint publications

Shigeo Shimose

5 joint publications

Motoyuki Otsuka